SOX9 antibody (AA 400-509)
-
- Target See all SOX9 Antibodies
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Binding Specificity
- AA 400-509
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This SOX9 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)
- Purpose
- Mouse monoclonal antibody raised against a partial recombinant SOX9.
- Sequence
- EQLSPSHYSE QQQHSPQQIA YSPFNLPHYS PSYPPITRSQ YDYTDHQNSS SYYSHAAGQG TGLYSTFTYM NPAQRPMYTP IADTSGVPSI PQTHSPQHWE QPVYTQLTRP
- Cross-Reactivity
- Human
- Characteristics
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- SOX9 (NP_000337, 400 a.a. ~ 509 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Clone
- 3C10
- Isotype
- IgG2a
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- In 1x PBS, pH 7.4
- Handling Advice
- Aliquot to avoid repeated freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio." in: Tissue engineering. Part A, Vol. 21, Issue 1-2, pp. 115-23, (2015) (PubMed).
: "Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome." in: Journal of clinical pathology, Vol. 67, Issue 2, pp. 125-33, (2014) (PubMed).
: "Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression." in: Journal of neuro-oncology, Vol. 112, Issue 2, pp. 191-7, (2013) (PubMed).
: "A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue." in: The American journal of pathology, Vol. 177, Issue 4, pp. 1674-86, (2010) (PubMed).
: "
-
In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio." in: Tissue engineering. Part A, Vol. 21, Issue 1-2, pp. 115-23, (2015) (PubMed).
-
- Target
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
- Alternative Name
- SOX9 (SOX9 Products)
- Synonyms
- CMD1 antibody, CMPD1 antibody, SRA1 antibody, LOC100227849 antibody, 2010306G03Rik antibody, AV220920 antibody, mKIAA4243 antibody, SOX-9 antibody, cmd1 antibody, cmpd1 antibody, sox-9 antibody, sox9 antibody, sox9-a antibody, sox9-b antibody, sox9b antibody, sra1 antibody, SRY-box 9 antibody, transcription factor SOX-9 antibody, SRY (sex determining region Y)-box 9 antibody, SRY box 9 antibody, SRY-box 9 L homeolog antibody, SOX9 antibody, LOC100227849 antibody, Sox9 antibody, sox9.L antibody
- Background
-
Full Gene Name: SRY (sex determining region Y)-box 9
Synonyms: CMD1,CMPD1,SRA1 - Gene ID
- 6662
- NCBI Accession
- NM_000346
- Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
-